Massachusetts medical device maker Abiomed lands reimbursement coding and payment for its Impella heart pump from regulators in the Netherlands.
Abiomed (NSDQ:ABMD) today announced that its Impella technology won reimbursement coding and payment from healthcare regulators in the Netherlands.
The Danvers, Mass.-based medical device company called the win a "significant milestone" for its flagship Impella device, which the company calls the "world's smallest heart pump."
Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
By Justine Cadet
Advances in medical care sometimes present challenges on the flipside. Case in point: Over the past three decades, progressive developments in pediatric cardiac care have allowed many babies born with congenital heart disease (CHD) to survive. And longevity continues to improve. This progress, however, has brought hospitals a burgeoning patient population with tremendously complex and varied disease states.
Getinge Group's medical device subsidiary Maquet Cardiovascular buys LAAx and its TigerPaw heart implant.
Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular said it bought LAAx Inc and its TigerPaw II heart implant for an undisclosed amount.
Medical device giant Medtronic announces CE Mark approval in the European Union and imminent commercial launch of its Export Advance thrombus removal system.
Medical device industry titan Medtronic (NYSE:MDT) announced today that it won CE Mark approval in the European Union for its latest thrombus removal system, the Export Advance aspiration catheter.
The new device, the latest in the Export family, will hit the shelves "soon" in Europe and other international markets, Medtronic reported.
Regulators in the European Union green-light St. Jude Medical's Ilumien Optis 3D vessel reconstruction technology to guide coronary stent placement.
St. Jude Medical (NYSE:STJ) today announced CE Mark approval of its Ilumien Optis PCI optimization system, designed to help physicians assess and treat patients with coronary artery disease.
The FDA warns healthcare providers of a Class I recall of some of Maquet Cardiovascular's malfunctioning battery units.
A Class I recall, reserved for serious patient harm, was issued over battery units produced by Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular.
California mobile medical device maker AliveCor releases a new model of its ECG monitoring and recording technology to fit the size and shape of the iPhone 5 and plans to hand out free samples at the Heart Rhythm Society meeting in Denver, Colo.
California startup AliveCor updated its heart monitor to make it compatible with the next-generation iPhone 5. The company's mobile ECG snaps on to the outside of an iPhone with sensors that monitor and record electrocardiogram rhythms wirelessly.